Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients

Blood

Volumn 118, Issue 20, 2011, Pages 5416-5419

  Potenza, Leonardo ^a   Vallerini, Daniela ^a   Barozzi, Patrizia ^a   Riva, Giovanni ^a   Forghieri, Fabio ^a   Zanetti, Eleonora ^a   Quadrelli, Chiara ^a   Candoni, Anna ^b   Maertens, Johan ^c   Rossi, Giulio ^a   Morselli, Monica ^a   Codeluppi, Mauro ^a   Paolini, Ambra ^a   Maccaferri, Monica ^a   Del Giovane, Cinzia ^a   D'Amico, Roberto ^a   Rumpianesi, Fabio ^a   Pecorari, Monica ^a   Cavalleri, Francesca ^a   Marasca, Roberto ^a   Narni, Franco ^a   Luppi, Mario ^a   more..

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Hematology and Bone Marrow Transplantation   (Italy)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4;

ARTICLE; CLINICAL ARTICLE; FUNGUS HYPHAE; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; INVASIVE MUCORMYCOSIS; MUCORALES; MUCORMYCOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 81555196379     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-07-366526     Document Type: Article

References (21)

1. Hibbett DS, Binder M, Bischoff JF, et al. A higher-level phylogenetic classification of the Fungi. Mycol Res. 2007;111(pt 5):509-547. (Pubitemid 46915419)
2. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis. 2010;50(8):1091-1100.
3. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica. 2006;91(8):1068-1075. (Pubitemid 44208634)
4. Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica. 2006;91(7):986-989. (Pubitemid 44023159)
5. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47:503-509.
6. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-1821.
7. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634-653. (Pubitemid 41170352)
8. Bialek R, Konrad F, Kern J, et al. PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J Clin Pathol. 2005;58(11):1180-1184. (Pubitemid 41566463)
9. Dannaoui E, Schwarz P, Slany M, et al. Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluation. J Clin Microbiol. 2010;48(6):2043-2046.
10. Romani L. Immunity to fungal infections. Nat Rev Immunol. 2004;4(1):1-23.
11. Hebart H, Bollinger C, Fisch P, et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood. 2002;100(13):4521-4528. (Pubitemid 35429693)
12. Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet. 2001;357(9273):2017-2021. (Pubitemid 32592390)
13. Potenza L, Barozzi P, Vallerini D, et al. Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates. Leukemia. 2007;21(10):578-581.
14. Riva G, Luppi M, Barozzi P, et al. Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment. Blood. 2010;115(8):1512-1518.
15. Potenza L, Luppi M, Barozzi P, et al. HHV-6A in syncytial giant-cell hepatitis. N Engl J Med. 2008;359(6):593-602.
16. Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ. Interferon-gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis. 2005;191(7):1180-1187. (Pubitemid 40404378)
17. Bozza S, Clavaud C, Giovannini G, et al. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J Immunol. 2009;183(4):2407-2414.
18. Ramadan G, Davies B, Kurup VP, Keever-Taylor CA. Generation of cytotoxic T cell responses directed to human leucocyte antigen class I restricted epitopes from the Aspergillus f16 allergen. Clin Exp Immunol. 2005;140(1):81-91. (Pubitemid 40461076)
19. Chai LY, van de Veerdonk F, Marijnissen RJ, et al. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology. 2010;130(1):46-54.
20. van Crevel R, Karyadi E, Preyers F, et al. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis. 2000;181(3):1194-1197. (Pubitemid 30194515)
21. Elrefaei M, Burke CM, Baker CA, et al. TGF-beta and IL-10 production by HIV-specific CD8+T cells is regulated by CTLA-4 signaling on CD4+ T cells. PLoS One. 2009;4(12):e8194.